(PDF) Systemic Adoptive T-Cell Immunotherapy in Recurrent

Systemic Adoptive T-Cell Immunotherapy in Recurrent and Metastatic Carcinoma of the Head and Neck

Archives of Otolaryngology–Head & Neck Surgery

doi 10.1001/archotol.126.10.1225

Full Text

Abstract

Available in full text

Date

October 1, 2000

Authors

Benjamin G. Wood

Marshall Strome

Ramon M. Esclamado

Gregory E. Plautz

Kate Sandstrom-Wakeling

Publisher

American Medical Association (AMA)

Related search

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation

English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology

English

Current Recommendations for Systemic Therapy of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Journal of the National Comprehensive Cancer Network : JNCCN

English

Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France

Value in Health

Occupational Health

English

Adoptive T-Cell Transfer and Chemotherapy in the First-Line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

Molecular Therapy

Molecular Medicine

Molecular Biology

English

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology–Head & Neck Surgery

English

Enhanced Local and Systemic Anti-Melanoma CD8+ T Cell Responses After Memory T Cell-Based Adoptive Immunotherapy in Mice

Cancer Immunology, Immunotherapy

Cancer Research

English

Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Evaluation in Latin America

Biomedical Journal of Scientific & Technical Research

English

Successful Treatment of Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck Using Pembrolizumab

Opuholi Golovy i Sei

Cancer Research

Nuclear Medicine

Otorhinolaryngology

English